Impact of ICU on the Quality of Life in Cancer Patients
This is an observational, prospective, monocentric, case-control study. Investigators aim to compare the quality of life and oncological treatment strategy in cancer patients admitted or not in ICU.
Solid Tumor, Adult
OTHER: Questionnaires
quality of life questionary 36-item short form survey instrument (36-SF), score of 0 (poor quality of life) to 100 (very good quality of life), 3 months
intensity of antitumoral treatment compared to standard treatment, standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer), 3 months|quality of life questionary 36-item short form survey instrument (36-SF), score of 0 (poor quality of life) to 100 (very good quality of life), 6 months|intensity of antitumoral treatment compared to standard treatment, standard treatment vs adaptated treatment vs palliative care standard treatment was defined by the treatment recommended in the ESMO guidelines for each cancer (lung, colorectal, and head and neck cancer), 6 months|ECOG - Performance status, From 0 (fully active) to 5 (dead), 3 months and 6 months|Activities of Daily Living, From 0 (dependent ) to 6 (autonomous), 6 months|Hospital Anxiety and Depression Scale, Anxiety scale from 0 (no anxiety) to 21 (anxiety) Depression Scale from 0 (no depression) to 21 (depression), 3 months and 6 months
Inclusion of cancer patients (cases) at discharge of surgical, cardiovascular and thoracic and medical ICU of the Grenoble Alpes University Hospital.

Cases will be matched with cancer patients identified in oncologist's consultation.

Inclusion of controls from oncologist consultations (2 controls for 1 case) For cases and controls, medical data will be collected at inclusion, 3 and 6 months.